Research Project

Project Title:	A Phase 2b/3, Multi-part, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With IgA Nephropathy (IgAN)
Project Type:	Clinical Trial, Enrolment ongoing
Disease group(s):	Immune glomerulopathies
Project Summary:	A Phase 3 Study with Atacicept in Subjects With IgA Nephropathy (ORIGIN 3)
Lead principal investigator(s):	Smaragdi Marinaki, Athens
Co-investigator(s):	Eleni Kapsia, Athens
Project Period:	05/2023 - 07/2028
Sponsors:	Industry
Project web page:	https://www.theoriginiganstudy.com/us-en/origin3-study
ClinicalTrials.gov:	NCT04716231
EudraCT Nr.:	2023-503772-24-00